サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1577185

先進創傷治療・閉鎖市場の2030年までの予測：製品タイプ、創傷タイプ、エンドユーザー、地域別の世界分析

Advanced Wound Care and Closure Market Forecasts to 2030 - Global Analysis By Product Type (Dressings, Negative Pressure Wound Therapy, Skin Substitutes and Other Product Types), Wound Type, End User and By Geography

出版日
ページ情報
英文 200+ Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
先進創傷治療・閉鎖市場の2030年までの予測：製品タイプ、創傷タイプ、エンドユーザー、地域別の世界分析
出版日: 2024年10月10日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の先進創傷治療・閉鎖市場は2024年に222億米ドルを占め、2030年には332億米ドルに達すると予測され、予測期間中のCAGRは6.2%で成長する見込みです。

創傷治療と閉鎖は、外傷や手術による急性創傷、糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍などの慢性創傷など、複雑な創傷を管理し治癒を早めるために使用される専門的な医療介入と製品です。高度なドレッシング材、皮膚代用剤、陰圧創傷治療（NPWT）、組織接着剤、ステープル、縫合糸などの創傷閉鎖製品がすべて含まれます。これらの治療薬は、患者の転帰を改善し、治癒を促進し、感染を阻止しようとするものです。

米国政府の推計によると、2060年までに高齢者人口は7,700万人を超えます。米国全体では、全人口の約2％が慢性創傷を患っていると推定されています。

慢性疾患の増加

糖尿病、肥満、心血管障害などの慢性疾患の増加は、高度創傷治療・閉鎖市場の重要な促進要因です。これらの疾患は糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍などの慢性創傷につながることが多く、高度創傷ケアソリューションが必要となります。これらの疾患にかかりやすい高齢化人口の増加が、この動向をさらに加速させています。慢性創傷を持つ患者の増加に伴い、先進的な創傷ケア製品や技術に対する需要が高まり、市場成長の原動力となっています。

高度創傷治療製品の高価格

高度創傷治療製品の高価格が市場成長の大きな抑制要因となっています。これらの製品には高度な技術や材料が組み込まれていることが多く、その結果製造コストが高くなり、その結果エンドユーザーの価格も高くなります。特に発展途上国やヘルスケアの適用範囲が限定されている地域では、多くの患者にとって高額な出費となる可能性があります。このようなコスト要因は、特定の地域における採用率の低下や市場浸透の限定につながる可能性があります。

再生医療の進歩

再生医療の進歩は、損傷した組織や臓器の修復、置換、再生に焦点を当てており、複雑な創傷治癒に対する有望な解決策を提供しています。幹細胞治療、組織工学、成長因子などの技術革新により、慢性および急性の創傷治療に新たな道が開かれつつあります。これらの技術は治癒を早め、瘢痕を減らし、患者の予後を改善する可能性を秘めています。研究が進み臨床応用が拡大するにつれて、再生医療アプローチは先進的な創傷治療プロトコールに組み込まれるようになると思われます。

製品リコールと安全性への懸念

製品の欠陥、副作用、予期せぬ合併症の発生はリコールにつながる可能性があり、主要企業の評判と消費者の信頼の両方を損なう。このような事態は、規制当局の監視、法的責任、製造業者の経済的損失につながる可能性があります。また、医療従事者がより慎重になるため、安全性への懸念が新技術の採用を遅らせる可能性もあります。さらに、こうした問題をめぐる否定的な宣伝は業界全体に影響を与え、市場の成長を鈍らせる可能性があります。

COVID-19の影響：

COVID-19のパンデミックは当初、高度創傷ケアおよび創傷閉鎖市場を混乱させ、サプライチェーンの問題や緊急処置以外の処置の延期を引き起こしました。しかし、COVID-19患者の合併症予防における高度創傷ケアの重要性も浮き彫りになった。パンデミックは創傷治療管理への遠隔医療ソリューションの採用を加速させ、創傷治療プロトコールにおける感染対策の必要性を強調しました。こうした変化は市場動向や製品開拓に永続的な影響を与えると思われます。

予測期間中、ドレッシング材分野が最大となる見込み

予測期間中、ドレッシング材分野が市場シェアを独占すると予測されます。この優位性は、フォームドレッシング、ハイドロコロイドドレッシング、アルジネートドレッシング、抗菌ドレッシングなど幅広い種類のドレッシングがあり、それぞれが特定の創傷タイプや治癒段階に対応していることに起因しています。慢性潰瘍から手術創まで、さまざまな創傷の状態に対応できる高度なドレッシング材の汎用性と有効性が、その普及に貢献しています。さらに、創傷モニタリング用のセンサーを備えたスマートドレッシングなど、ドレッシング材の素材やデザインにおける技術革新が進んでいることも、このセグメントの成長をさらに後押ししています。

陰圧創傷治療（NPWT）分野は予測期間中に最も高いCAGRが見込まれる

予測期間中、陰圧創傷治療（NPWT）分野は最も高いCAGRで成長すると予想されます。この急成長の背景には、複雑で治りにくい創傷の管理にNPWTが有効であるという認識が高まっていることがあります。NPWTシステムは、過剰な体液を除去し、浮腫を軽減し、肉芽組織形成を刺激する制御された陰圧環境を作り出すことによって、より早い治癒を促進します。外科的創傷、褥瘡、糖尿病性足潰瘍など、さまざまなタイプの創傷を治療できる汎用性が、この技術の採用拡大に寄与しています。

最もシェアが高い地域：

予測期間中、北米地域が最大の市場シェアを占めると予想されます。この優位性は、同地域の確立されたヘルスケアインフラ、高い医療費、先進医療技術の早期導入など、いくつかの要因によるものと考えられます。また、複雑な創傷につながることが多い糖尿病や肥満などの慢性疾患の有病率も北米の方が高いです。同地域は主要市場プレイヤーのプレゼンスが高く、技術革新と製品供給を促進しています。さらに、先進的な創傷治療製品に対する有利な償還政策や高齢化人口の増加が市場規模に貢献しています。

CAGRが最も高い地域：

アジア太平洋地域は予測期間中に最も高いCAGRを達成すると予測されます。この急成長の背景には、この地域の人口増加、ヘルスケア支出の増加、ヘルスケアインフラの改善などいくつかの要因があります。慢性疾患の有病率の上昇に加え、高度な創傷治療技術に対する意識の高まりが市場拡大の原動力となっています。中国やインドなどの各国政府はヘルスケアの近代化に多額の投資を行っており、先進創傷治療の導入機会を創出しています。この地域の医療ツーリズム産業の拡大も市場拡大に寄与しています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場プレーヤーの包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査情報源
    • 1次調査情報源
    • 2次調査情報源
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の先進創傷治療・閉鎖市場：製品タイプ別

  • ドレッシング
    • アルギン酸
    • ハイドロコロイド
    • ハイドロゲル
    • フォーム
    • その他のドレッシング
  • 陰圧閉鎖療法（NPWT）
  • 皮膚代替品
  • 傷口洗浄剤と消毒剤
  • 縫合糸とステープル
    • 吸収性縫合糸
    • 非吸収性縫合糸
    • 外科用ステープル
  • 接着剤とシーラント
    • 組織接着剤
    • 外科用シーラント
  • 創傷ケア機器
    • デブリードマンツール
    • 創傷洗浄システム
    • その他の創傷ケア機器

第6章 世界の先進創傷治療・閉鎖市場：創傷タイプ別

  • 慢性創傷
    • 糖尿病性足潰瘍
    • 褥瘡
    • 静脈性下肢潰瘍
    • その他の慢性創傷
  • 急性創傷
    • 手術創
    • 外傷
    • バーンズ
    • その他の急性創傷

第7章 世界の先進創傷治療・閉鎖市場：エンドユーザー別

  • 病院
  • 在宅ヘルスケア
  • 外来手術センター（ASC）
  • 創傷ケアセンター
  • その他のエンドユーザー

第8章 世界の先進創傷治療・閉鎖市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイリング

  • 3M Company
  • Smith & Nephew plc
  • ConvaTec Group plc
  • Coloplast A/S
  • Molnlycke Health Care AB
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Medtronic plc
  • Cardinal Health, Inc.
  • Paul Hartmann AG
  • Integra LifeSciences Holdings Corporation
  • Baxter International Inc.
  • Essity AB
  • Acelity L.P. Inc.
  • Organogenesis Holdings Inc.
  • Hollister Incorporated
  • MiMedx Group, Inc.
  • Ethicon, Inc.
図表

List of Tables

  • Table 1 Global Advanced Wound Care and Closure Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Advanced Wound Care and Closure Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Advanced Wound Care and Closure Market Outlook, By Dressings (2022-2030) ($MN)
  • Table 4 Global Advanced Wound Care and Closure Market Outlook, By Alginate (2022-2030) ($MN)
  • Table 5 Global Advanced Wound Care and Closure Market Outlook, By Hydrocolloid (2022-2030) ($MN)
  • Table 6 Global Advanced Wound Care and Closure Market Outlook, By Hydrogel (2022-2030) ($MN)
  • Table 7 Global Advanced Wound Care and Closure Market Outlook, By Foam (2022-2030) ($MN)
  • Table 8 Global Advanced Wound Care and Closure Market Outlook, By Other Dressings (2022-2030) ($MN)
  • Table 9 Global Advanced Wound Care and Closure Market Outlook, By Negative Pressure Wound Therapy (NPWT) (2022-2030) ($MN)
  • Table 10 Global Advanced Wound Care and Closure Market Outlook, By Skin Substitutes (2022-2030) ($MN)
  • Table 11 Global Advanced Wound Care and Closure Market Outlook, By Wound Cleansers and Disinfectants (2022-2030) ($MN)
  • Table 12 Global Advanced Wound Care and Closure Market Outlook, By Sutures and Staples (2022-2030) ($MN)
  • Table 13 Global Advanced Wound Care and Closure Market Outlook, By Absorbable Sutures (2022-2030) ($MN)
  • Table 14 Global Advanced Wound Care and Closure Market Outlook, By Non-Absorbable Sutures (2022-2030) ($MN)
  • Table 15 Global Advanced Wound Care and Closure Market Outlook, By Surgical Staples (2022-2030) ($MN)
  • Table 16 Global Advanced Wound Care and Closure Market Outlook, By Adhesives and Sealants (2022-2030) ($MN)
  • Table 17 Global Advanced Wound Care and Closure Market Outlook, By Tissue Adhesives (2022-2030) ($MN)
  • Table 18 Global Advanced Wound Care and Closure Market Outlook, By Surgical Sealants (2022-2030) ($MN)
  • Table 19 Global Advanced Wound Care and Closure Market Outlook, By Wound Care Devices (2022-2030) ($MN)
  • Table 20 Global Advanced Wound Care and Closure Market Outlook, By Debridement Tools (2022-2030) ($MN)
  • Table 21 Global Advanced Wound Care and Closure Market Outlook, By Wound Irrigation Systems (2022-2030) ($MN)
  • Table 22 Global Advanced Wound Care and Closure Market Outlook, By Other Wound Care Devices (2022-2030) ($MN)
  • Table 23 Global Advanced Wound Care and Closure Market Outlook, By Wound Type (2022-2030) ($MN)
  • Table 24 Global Advanced Wound Care and Closure Market Outlook, By Chronic Wounds (2022-2030) ($MN)
  • Table 25 Global Advanced Wound Care and Closure Market Outlook, By Diabetic Foot Ulcers (2022-2030) ($MN)
  • Table 26 Global Advanced Wound Care and Closure Market Outlook, By Pressure Ulcers (2022-2030) ($MN)
  • Table 27 Global Advanced Wound Care and Closure Market Outlook, By Venous Leg Ulcers (2022-2030) ($MN)
  • Table 28 Global Advanced Wound Care and Closure Market Outlook, By Other Chronic Wounds (2022-2030) ($MN)
  • Table 29 Global Advanced Wound Care and Closure Market Outlook, By Acute Wounds (2022-2030) ($MN)
  • Table 30 Global Advanced Wound Care and Closure Market Outlook, By Surgical Wounds (2022-2030) ($MN)
  • Table 31 Global Advanced Wound Care and Closure Market Outlook, By Traumatic Wounds (2022-2030) ($MN)
  • Table 32 Global Advanced Wound Care and Closure Market Outlook, By Burns (2022-2030) ($MN)
  • Table 33 Global Advanced Wound Care and Closure Market Outlook, By Other Acute Wounds (2022-2030) ($MN)
  • Table 34 Global Advanced Wound Care and Closure Market Outlook, By End User (2022-2030) ($MN)
  • Table 35 Global Advanced Wound Care and Closure Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 36 Global Advanced Wound Care and Closure Market Outlook, By Home Healthcare (2022-2030) ($MN)
  • Table 37 Global Advanced Wound Care and Closure Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 38 Global Advanced Wound Care and Closure Market Outlook, By Wound Care Centers (2022-2030) ($MN)
  • Table 39 Global Advanced Wound Care and Closure Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC27503

According to Stratistics MRC, the Global Advanced Wound Care and Closure Market is accounted for $22.2 billion in 2024 and is expected to reach $33.2 billion by 2030, growing at a CAGR of 6.2% during the forecast period. Advanced wound care and closure are specialized medical interventions and products used to manage and speed up the healing of complex wounds, such as acute wounds from trauma or surgery, as well as chronic wounds like diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Advanced dressings, skin substitutes, negative pressure wound therapy (NPWT), and closure products such as tissue adhesives, staples, and sutures are all included. These remedies seek to improve patient outcomes, promote healing, and stop infection.

According to the U.S. government estimates, by the year 2060, the elderly population will be over 77 million. Overall, in the United States approximately 2% of the total population are estimated to be affected by chronic wounds.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular disorders, is a significant driver for the advanced wound care and closure market. These conditions often lead to chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, which require advanced wound care solutions. The growing aging population, which is more susceptible to these diseases, further amplifies this trend. As the number of patients with chronic wounds rises, the demand for advanced wound care products and technologies increases, driving market growth.

Restraint:

High cost of advanced wound care products

The high cost of advanced wound care products poses a significant restraint to market growth. These products often incorporate sophisticated technologies and materials, resulting in higher production costs and, consequently, higher prices for end-users. The expense can be prohibitive for many patients, especially in developing countries or areas with limited healthcare coverage. The cost factor can lead to slower adoption rates and limited market penetration in certain regions.

Opportunity:

Advancements in regenerative medicine

Advancements in regenerative medicine focus on repairing, replacing, or regenerating damaged tissues and organs, offering promising solutions for complex wound healing. Innovations in stem cell therapy, tissue engineering, and growth factors are opening new avenues for treating chronic and acute wounds. These technologies have the potential to accelerate healing, reduce scarring, and improve overall patient outcomes. As research progresses and clinical applications expand, regenerative medicine approaches are likely to become more integrated into advanced wound care protocols.

Threat:

Product recalls and safety concerns

Incidents of product defects, adverse reactions, or unforeseen complications can lead to recalls, damaging both company reputations and consumer trust. Such events may result in regulatory scrutiny, legal liabilities, and financial losses for manufacturers. Safety concerns can also slow down the adoption of new technologies as healthcare providers become more cautious. Additionally, negative publicity surrounding these issues can impact the entire industry, potentially slowing market growth.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the advanced wound care and closure market, causing supply chain issues and postponement of non-emergency procedures. However, it also highlighted the importance of advanced wound care in preventing complications in COVID-19 patients. The pandemic accelerated the adoption of telehealth solutions for wound care management and emphasized the need for infection control measures in wound treatment protocols. These changes are likely to have lasting effects on market trends and product development.

The dressings segment is expected to be the largest during the forecast period

Over the forecasted timeframe, the dressings segment is anticipated to dominate the market share. This dominance can be attributed to the wide range of dressing types available, including foam dressings, hydrocolloid dressings, alginate dressings, and antimicrobial dressings, each catering to specific wound types and healing stages. The versatility and effectiveness of advanced dressings in managing various wound conditions, from chronic ulcers to surgical wounds, contribute to their widespread use. Additionally, ongoing innovations in dressing materials and designs, such as smart dressings with sensors for wound monitoring, are further driving the segment's growth.

The negative pressure wound therapy (NPWT) segment is expected to have the highest CAGR during the forecast period

During the projection period, the negative pressure wound therapy (NPWT) segment is expected to grow at the highest CAGR. This rapid growth can be attributed to the increasing recognition of NPWT's effectiveness in managing complex and hard-to-heal wounds. NPWT systems promote faster healing by creating a controlled negative pressure environment that removes excess fluid, reduces edema, and stimulates granulation tissue formation. The technology's versatility in treating various wound types, including surgical wounds, pressure ulcers, and diabetic foot ulcers, contributes to its growing adoption.

Region with largest share:

During the estimation period, the North America region is expected to capture the largest market share. This dominance can be attributed to several factors, including the region's well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. The prevalence of chronic diseases such as diabetes and obesity, which often lead to complex wounds, is also higher in North America. The region benefits from a strong presence of key market players, driving innovation and product availability. Additionally, favorable reimbursement policies for advanced wound care products and a growing aging population contribute to the market's size.

Region with highest CAGR:

The Asia Pacific region is projected to achieve the highest CAGR during the forecast period. This rapid growth can be attributed to several factors, including the region's large and growing population, increasing healthcare expenditure, and improving healthcare infrastructure. The rising prevalence of chronic diseases, coupled with a growing awareness of advanced wound care techniques, is driving market expansion. Governments in countries like China and India are investing heavily in healthcare modernization, creating opportunities for advanced wound care adoption. The region's expanding medical tourism industry also contributes to market growth.

Key players in the market

Some of the key players in Advanced Wound Care and Closure Market include 3M Company, Smith & Nephew plc, ConvaTec Group plc, Coloplast A/S, Molnlycke Health Care AB, B. Braun Melsungen AG, Johnson & Johnson, Medtronic plc, Cardinal Health, Inc., Paul Hartmann AG, Integra LifeSciences Holdings Corporation, Baxter International Inc., Essity AB, Acelity L.P. Inc., Organogenesis Holdings Inc., Hollister Incorporated, MiMedx Group, Inc., and Ethicon, Inc.

Key Developments:

In October 2024, Molnlycke Health Care AB acquired P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn wound cleansing and moisturizing solutions, to expand its wound care portfolio.

In April 2024, Smith+Nephew, the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact, allowing it to be easily carried or worn. It features a discreet canister and operates quietly so as not to draw attention or disturb the patients' daily activities.

In January 2024, 3M Company received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity to develop new solutions for infection prevention, wound management, and wound healing, focusing on treatment strategies for emergency settings and mass casualty situations.

Product Types Covered:

  • Dressings
  • Negative Pressure Wound Therapy (NPWT)
  • Skin Substitutes
  • Wound Cleansers and Disinfectants
  • Sutures and Staples
  • Adhesives and Sealants
  • Wound Care Devices

Wound Types Covered:

  • Chronic Wounds
  • Acute Wounds

End Users Covered:

  • Hospitals
  • Home Healthcare
  • Ambulatory Surgical Centers (ASCs)
  • Wound Care Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Advanced Wound Care and Closure Market, By Product Type

  • 5.1 Introduction
  • 5.2 Dressings
    • 5.2.1 Alginate
    • 5.2.2 Hydrocolloid
    • 5.2.3 Hydrogel
    • 5.2.4 Foam
    • 5.2.5 Other Dressings
  • 5.3 Negative Pressure Wound Therapy (NPWT)
  • 5.4 Skin Substitutes
  • 5.5 Wound Cleansers and Disinfectants
  • 5.6 Sutures and Staples
    • 5.6.1 Absorbable Sutures
    • 5.6.2 Non-Absorbable Sutures
    • 5.6.3 Surgical Staples
  • 5.7 Adhesives and Sealants
    • 5.7.1 Tissue Adhesives
    • 5.7.2 Surgical Sealants
  • 5.8 Wound Care Devices
    • 5.8.1 Debridement Tools
    • 5.8.2 Wound Irrigation Systems
    • 5.8.3 Other Wound Care Devices

6 Global Advanced Wound Care and Closure Market, By Wound Type

  • 6.1 Introduction
  • 6.2 Chronic Wounds
    • 6.2.1 Diabetic Foot Ulcers
    • 6.2.2 Pressure Ulcers
    • 6.2.3 Venous Leg Ulcers
    • 6.2.4 Other Chronic Wounds
  • 6.3 Acute Wounds
    • 6.3.1 Surgical Wounds
    • 6.3.2 Traumatic Wounds
    • 6.3.3 Burns
    • 6.3.4 Other Acute Wounds

7 Global Advanced Wound Care and Closure Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Home Healthcare
  • 7.4 Ambulatory Surgical Centers (ASCs)
  • 7.5 Wound Care Centers
  • 7.6 Other End Users

8 Global Advanced Wound Care and Closure Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Company
  • 10.2 Smith & Nephew plc
  • 10.3 ConvaTec Group plc
  • 10.4 Coloplast A/S
  • 10.5 Molnlycke Health Care AB
  • 10.6 B. Braun Melsungen AG
  • 10.7 Johnson & Johnson
  • 10.8 Medtronic plc
  • 10.9 Cardinal Health, Inc.
  • 10.10 Paul Hartmann AG
  • 10.11 Integra LifeSciences Holdings Corporation
  • 10.12 Baxter International Inc.
  • 10.13 Essity AB
  • 10.14 Acelity L.P. Inc.
  • 10.15 Organogenesis Holdings Inc.
  • 10.16 Hollister Incorporated
  • 10.17 MiMedx Group, Inc.
  • 10.18 Ethicon, Inc.